Tatsuya Ide

5.2k total citations · 1 hit paper
120 papers, 2.9k citations indexed

About

Tatsuya Ide is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tatsuya Ide has authored 120 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hepatology, 87 papers in Epidemiology and 16 papers in Infectious Diseases. Recurrent topics in Tatsuya Ide's work include Hepatitis C virus research (83 papers), Liver Disease Diagnosis and Treatment (59 papers) and Hepatitis B Virus Studies (52 papers). Tatsuya Ide is often cited by papers focused on Hepatitis C virus research (83 papers), Liver Disease Diagnosis and Treatment (59 papers) and Hepatitis B Virus Studies (52 papers). Tatsuya Ide collaborates with scholars based in Japan, United States and China. Tatsuya Ide's co-authors include Michio Sata, Yumiko Nagao, Takumi Kawaguchi, Ryukichi Kumashiro, Shigetoshi Fujiyama, Motohiko Tanaka, Shinichiro Hanada, Masao Omata, Osamu Yokosuka and Fumio Imazeki and has published in prestigious journals such as Blood, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Tatsuya Ide

105 papers receiving 2.8k citations

Hit Papers

Interferon Therapy Reduces the Risk for Hepatocellular Ca... 1999 2026 2008 2017 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsuya Ide Japan 20 2.2k 2.2k 301 182 178 120 2.9k
Gotaro Yamada Japan 26 2.2k 1.0× 2.1k 1.0× 265 0.9× 286 1.6× 173 1.0× 89 2.9k
Wen‐Yu Chang Taiwan 28 2.1k 1.0× 2.2k 1.0× 227 0.8× 147 0.8× 203 1.1× 86 2.8k
Anuchit Chutaputti Thailand 16 2.2k 1.0× 2.0k 0.9× 188 0.6× 176 1.0× 104 0.6× 30 2.6k
Massimo Colombo Italy 29 3.2k 1.5× 3.2k 1.5× 227 0.8× 265 1.5× 182 1.0× 98 4.1k
Ming‐Lun Yeh Taiwan 26 1.8k 0.8× 1.7k 0.8× 191 0.6× 296 1.6× 98 0.6× 193 2.4k
Tai‐Chung Tseng Taiwan 34 3.5k 1.6× 3.4k 1.5× 232 0.8× 163 0.9× 82 0.5× 166 4.1k
Anita Kohli United States 24 1.5k 0.7× 1.2k 0.6× 249 0.8× 180 1.0× 96 0.5× 77 2.2k
David Sheridan United Kingdom 15 2.3k 1.0× 2.2k 1.0× 182 0.6× 251 1.4× 413 2.3× 36 2.9k
Fusao Ikeda Japan 26 1.3k 0.6× 1.5k 0.7× 320 1.1× 268 1.5× 201 1.1× 115 2.3k
Luisa Garcı́a-Buey Spain 24 1.3k 0.6× 1.4k 0.6× 308 1.0× 188 1.0× 278 1.6× 70 2.3k

Countries citing papers authored by Tatsuya Ide

Since Specialization
Citations

This map shows the geographic impact of Tatsuya Ide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Ide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Ide more than expected).

Fields of papers citing papers by Tatsuya Ide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuya Ide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Ide. The network helps show where Tatsuya Ide may publish in the future.

Co-authorship network of co-authors of Tatsuya Ide

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuya Ide. A scholar is included among the top collaborators of Tatsuya Ide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuya Ide. Tatsuya Ide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kuromatsu, Ryoko, Tatsuya Ide, Shusuke Okamura, et al.. (2022). Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer. Cancers. 14(9). 2295–2295. 5 indexed citations
3.
Arinaga‐Hino, Teruko, Hironori Koga, Jun Akiba, et al.. (2018). Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter‐3 in immunoglobulin G4‐related autoimmune hepatitis. Hepatology Research. 48(11). 937–944. 6 indexed citations
4.
Arinaga‐Hino, Teruko, Tatsuya Ide, Ichiro Miyajima, et al.. (2017). Risk of malignancies in autoimmune hepatitis type 1 patients with a long‐term follow‐up in Japan. Hepatology Research. 48(3). 9 indexed citations
6.
Ide, Tatsuya, et al.. (2010). Generalized System of Mono- and Bi-Propellant Propulsion for Microsatellite. TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES AEROSPACE TECHNOLOGY JAPAN. 8(ists27). Pf_7–Pf_12. 1 indexed citations
7.
Fukushima, Nobuyoshi, Ryoko Kuromatsu, Teruko Arinaga‐Hino, et al.. (2010). Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C. Hepatology Research. 40(9). 911–922. 13 indexed citations
8.
Kawaguchi, Takumi, et al.. (2008). Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. International Journal of Molecular Medicine. 22(1). 105–12. 80 indexed citations
9.
10.
Kuwahara, Reiichiro, Ryukichi Kumashiro, Tatsuya Ide, et al.. (2008). Predictive Factors Associated with the Progression to Hepatic Failure Caused by Lamivudine-Resistant HBV. Digestive Diseases and Sciences. 53(11). 2999–3006. 1 indexed citations
11.
Kawaguchi, Takumi, Tatsuya Ide, Eitaro Taniguchi, et al.. (2007). Clearance of HCV Improves Insulin Resistance, Beta-Cell Function, and Hepatic Expression of Insulin Receptor Substrate 1 and 2. The American Journal of Gastroenterology. 102(3). 570–576. 202 indexed citations
12.
Ide, Tatsuya, Ryukichi Kumashiro, Reiichiro Kuwahara, et al.. (2005). Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment. Journal of Gastroenterology. 40(6). 625–630. 5 indexed citations
13.
Ikeda, Masafumi, Shigetoshi Fujiyama, Motohiko Tanaka, et al.. (2005). Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. Journal of Gastroenterology. 40(2). 148–156. 101 indexed citations
14.
Ito, Kiyoaki, Yasuhito Tanaka, Etsuro Orito, et al.. (2004). Predicting Relapse after Cessation of Lamivudine Monotherapy for Chronic Hepatitis B Virus Infection. Clinical Infectious Diseases. 38(4). 490–495. 18 indexed citations
15.
Nagao, Yumiko, Shinichiro Hanada, Tatsuya Ide, et al.. (2003). Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 18(3). 258–266. 30 indexed citations
16.
Kumashiro, Ryukichi, Tatsuya Ide, Ichiro Miyajima, et al.. (2000). Effect of interferon treatment on serum 2?,5?-oligoadenylate synthetase levels in hepatitis C-infected patients. Journal of Medical Virology. 62(2). 185–190. 20 indexed citations
17.
Nagao, Yumiko, M Sata, Tatsuya Ide, et al.. (1996). Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. European Journal of Clinical Investigation. 26(12). 1171–1174. 54 indexed citations
19.
Ishii, Kunihide, Michio Sata, Ryukichi Kumashiro, et al.. (1990). Studies on anti-HCV in hepatocellular carcinoma with alcoholic cirrhosis.. Kanzo. 31(10). 1181–1185. 7 indexed citations
20.
Ide, Tatsuya. (1990). Studies on elevated serum IgM levels in primary biliary cirrhosis.. Kanzo. 31(11). 1315–1323. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026